Skip to main content


Guideline Updates

Guideline Updates
March 25, 2021
NCCN released an update to its clinical practice guideline for SCLC, including modifications for supportive care and subsequent systemic therapy.
Guideline Updates
March 25, 2021
NCCN released an update to its clinical practice guideline for SCLC, including modifications for supportive care and…
Guideline Updates
March 25, 2021
NCCN released an update to its clinical practice guideline for kidney cancer, featuring updates to first-line and…
Guideline Updates
March 24, 2021
NCCN released an update to its clinical practice guideline for central nervous system cancers, adding lorlatinib as a…
Guideline Updates
March 24, 2021
NCCN updated its clinical practice guideline for bladder cancer, removing atezolizumab as an alternative second-line…
Guideline Updates
March 17, 2021
NCCN released an update to its clinical practice guideline for B-cell lymphomas, featuring updates for follicular…
Guideline Updates
March 16, 2021
NCCN released an update to its clinical practice guideline for multiple myeloma, adding melphalan flufenamide/…
Guideline Updates
March 16, 2021
NCCN released an update to its clinical practice guideline for breast cancer, featuring extensive updates for invasive…
Guideline Updates
March 11, 2021
NCCN released an update to its clinical practice guideline for gastric cancer, including updates to second-line or…
Guideline Updates
March 11, 2021
NCCN released an update to its clinical practice guideline for esophageal and esophageal junction cancers, adding fam-…
Guideline Updates
March 10, 2021
NCCN released an update to its clinical practice guideline for bladder cancer.
Back to Top